May 22, 2025

New FDA-Approved Topical Foam for Scalp Psoriasis

The FDA has approved roflumilast (ZORYVE) foam 0.3% for once-daily treatment of plaque psoriasis in patients aged 12 and older, including hard-to-treat scalp and body areas..

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 22, 2025

New AAP Guidelines Refresh Atopic Dermatitis Care

Applying topicals 2 to 3 times per week to previously affected areas—even when the skin appears clear—can reduce flare frequency and improve quality of life.

Conexiant

May 22, 2025

Dual Inhaler Halves Mild Asthma Attacks in Trial

As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial.

Conexiant

May 22, 2025

HSV-1 Tied to Alzheimer’s: Study

In a matched case–control study of over 340,000 patients, researchers found that adults diagnosed with herpes simplex virus type 1 had higher odds of developing Alzheimer’s disease.

Conexiant

May 20, 2025

Creamy, Dreamy, and Possibly Dangerous

Emulsifiers keep foods creamy—but at what cost?

KFF Health News

May 20, 2025

Creamy, Dreamy, and Possibly Dangerous

Emulsifiers keep foods creamy—but at what cost?

KFF Health News

May 19, 2025

Protein-Based COVID Vaccine Gains FDA Approval

The FDA has approved the first recombinant protein-based, non-mRNA COVID-19 vaccine.

Conexiant

May 19, 2025

HIV/Hepatitis B Drug Class Shows Promise Against Alzheimer's

A longitudinal study across two major U.S. health databases found nucleoside reverse transcriptase inhibitors to be associated with reduced Alzheimer's disease incidence.

Conexiant